Business Context and Reporting Period
Company: IMPACT BIOMEDICAL INC.
Filing Type: Form 8-K (Current Report)
Date of Report: October 24, 2025
Event Date: October 24, 2025 (Earliest event reported)
Reporting Period: This filing reports a specific corporate event rather than a financial period.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing focuses exclusively on a capital structure event.
Material Changes
The primary material change reported is the conversion of Series A Convertible Preferred Stock into Common Stock:
- Holder: DSS BioHealth Security, Inc.
- Action: Elected to convert Series A Convertible Preferred Stock pursuant to Section 6 of the Certificate of Designation dated October 30, 2023.
- Conversion Terms: The conversion occurred 75 days after issuance, resulting in one share of Common Stock ($0.001 par value) for each share of Preferred Stock.
- Shares Issued: DSS BioHealth Security, Inc. is deemed the record holder of 60,496,041 shares of Common Stock.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, specific risks, contingencies, or unusual items beyond the disclosed conversion event.
Investor Verification Checklist
- Verify the total outstanding share count of Common Stock post-conversion to assess dilution impact.
- Confirm the ownership percentage of DSS BioHealth Security, Inc. following the issuance of 60,496,041 shares.
- Review the original Certificate of Designation (dated October 30, 2023) for any remaining conversion rights or liquidation preferences.
- Check for any subsequent filings regarding the registration rights or trading status of the newly issued shares.